An AI solution dedicated to the remote monitoring of MDD clinical severity stage

Machine learning & patient’s physiological features

MyndBlue is a digital MedTech company that develops a personalized & predictive clinical score combining physiological measurements from outpatients & artificial intelligence.

Our mission is to help physicians detect and monitor a patient’s daily clinical severity stage, which can be instrumental in clinical decision-making for MDD.*

*PTSD is also under research

Who are we, and what do we want to resolve?

We are a multisciplinary team of psychiatrists, clinical psychologists, pharmacists, mathematicians, & engineers whose passion is tackling tough challenges in the real world.

With a deep understanding of patient & physician’s needs we have designed a monitoring algorithm that is understandable and trustworthy.

Lack of objective biomarkers....

-MDD lacks biological markers to monitor MDD severity stage. Therefore, follow-up relies on clinical examination and the patient’s subjective reports, who may minimize or hide their symptoms. This makes it difficult to detect clinical severity changes and adjust treatment quickly.

-By using our AI solution, we are capable of monitoring a patient’s disease severity stage using physiological information tracked passively by a wearable. This solution is an exciting new approach to monitoring and assessing objective information for MDD.

Predictive Biosignature to build precision medicine

Our shared vision is to be at the forefront of building precision
medicine in mental health by relying on predictive AI.

MDD & PTSD : High-stake in numbers

30% of patients suffering from MDD have full recovery(1)

25% of patients suffering from MDD lost to monitor(2)

64% of patient suffering from acute PTSD evolve to chronic PTSD(3)

80% of chronic PTSD develop depression, bipolar or substance abuse disorder(4)

Publications & News

MHSRS (Military Health System Research Symposium)
August 26-29, 2024 Orlando

MyndBlue gave a TALK about our latest results on distinguishing PTSD and non PTSD in military population in the breakout session applications of AI in phychological disorders.

Motivated to join an inspiring project?

We are a passionate and committed team to build the augmented psychiatry of tomorrow. Our contribution will help physicians to improve clinical outcomes and patients to regain quality of life.
 
 
Current Openings
 
 
[contact-form-7 id="5" title="Formulaire de contact"]